Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 17.08 USD 1.85% Market Closed
Market Cap: 2.5B USD

Wall Street
Price Targets

DNLI Price Targets Summary
Denali Therapeutics Inc

Wall Street analysts forecast DNLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNLI is 32.86 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Lowest
Price Target
24.24 USD
42% Upside
Average
Price Target
32.86 USD
92% Upside
Highest
Price Target
42 USD
146% Upside
Denali Therapeutics Inc Competitors:
Price Targets
VLA
Valneva SE
106% Upside
AUPH
Aurinia Pharmaceuticals Inc
5% Upside
TLX
Telix Pharmaceuticals Ltd
140% Upside
2162
KeyMed Biosciences Inc
53% Upside
AMRN
Amarin Corporation PLC
11% Downside
ADOC
Adocia SA
140% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
65% Upside
EDIT
Editas Medicine Inc
106% Upside

Revenue
Forecast

Revenue Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DNLI's stock price target?
Price Target
32.86 USD

According to Wall Street analysts, the average 1-year price target for DNLI is 32.86 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Back to Top